She will report to Teresa Graham, CEO of Roche Pharma, and become a member of the group’s pharma leadership team. “Ashley is a Roche and Genentech veteran, with a 20-year career that spans the ...

Genentech, and Biogen in the race to market CD4, a drug that could potentially inhibit the infection of human cells by the AIDS virus. Precociousness is the corporate culture at this startup, whose ...

Genentech raised nearly $2 billion during its ... of investors' interest in biotechnology, says Steven Burrill, CEO of Burrill & Co. (San Francisco, CA). However, he points out that "the market ...